Events are FREE to qualified industry participants and decision-makers.

Evaluating Biopharma Events
Evaluating Biopharma Events
  • Home
  • Upcoming Events
    • Supply Chain Challenges
    • Process Intensification
    • Cell Therapy Strategies
    • Event Floorplan & Agenda
  • On Demand
    • On Demand Pharma
    • On Demand Tech
    • On Demand Operations
    • On Demand Continuous
  • Sponsorship
    • Sponsorship
    • Premier Sponsors
  • About Us
    • Evaluate Biopharma
  • More
    • Home
    • Upcoming Events
      • Supply Chain Challenges
      • Process Intensification
      • Cell Therapy Strategies
      • Event Floorplan & Agenda
    • On Demand
      • On Demand Pharma
      • On Demand Tech
      • On Demand Operations
      • On Demand Continuous
    • Sponsorship
      • Sponsorship
      • Premier Sponsors
    • About Us
      • Evaluate Biopharma
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out


Signed in as:

filler@godaddy.com

  • Home
  • Upcoming Events
  • On Demand
  • Sponsorship
  • About Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Registration Open! - Continuous Bioprocessing – Justifying Your Company’s Investment, June 16, 2022

Register Now!

Pharma Shifts to biologics roundtable

Pharma Shifts to Biologics Opening Remarks

Expanding Production Capacity for High Producing mAb Processes

Parrish Galliher (life science innovator, consultant w/BDO) and moderator Ben Locwin (executive, Black Diamond Networks) discuss how a large, well-established biotech company with an expanding pipeline addressed the technology and process requirements to support the necessary increase in production capacit

Read Summary Article

Raw Material Delay Derails PPQ Causing 2-Year Process Delay

Ron Bates (vice president, development and manufacturing, Immunovant) and Ben Locwin (executive, Black Diamond Networks) discuss how a small biotech small company with a low-demand Fc fusion protein identified, where addressed, and how then implemented a strategy to overcome PPQ failu

Read Summary Article

Overcoming Materials Supply Challenges

 Mark Petrich (vice president, technical operations, Krystal Biotech) and Ben Locwin (executive, Black Diamond Networks) discuss how material supply challenges can impact every biotech, large or small, equally - you either have what you need or you don't.  However, there are proactive strategies your company can implement to avoid or reduce delays caused by supply bottlenecks. 

Read Summary Article

Selecting the Right Facility Design/Tech to Support AAV Production/Scale

Dave Backer (chief commercial officer, Oxford Biomedica) and moderator Ben Locwin (executive, Black Diamond Networks) discuss the stark technology and process similarities and differences between cell/gene therapies and mAbs and the lessons that can be applied to accelerate AAV production and scale. 

Read Summary Article

Tech Options to Improve Low-Producing Biotherapeutic Processes

 Parrish Galliher (independent industry consultant) and Ben Locwin (executive, Black Diamond Networks) discuss how a small biotech start-up leveraged technology to accelerate production to compete with large biotech in the race to the clinic. 

Read Summary Article

CGT - Bridging the Technology Gap

 Dave Backer (chief commercial officer, Oxford Biomedica) and moderator Ben Locwin (executive Black Diamond Networks) discuss how the diversified and complex CGT market, currently in fed batch mode, is eyeing perfusion (where appropriate) is also experimenting with dedicated up/downstream technologies to improve recovery rates. 

Read Summary Article

Pharma Shifts to Biologics Closing Remarks

Copyright © 2022 Evaluating Biopharma Events - All Rights Reserved.

Powered by GoDaddy Website Builder

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept